| Stage | CNP | % of rev | LNT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $2.2B | 100.00% | $971M | 100.00% | CNP ×2.26 |
| Gross profit | $1.3B | 57.33% | $647M | 66.63% | LNT +9.3pp |
| Operating income | $667M | 30.44% | $185M | 19.05% | CNP +11.4pp |
| Pre-tax income | $413M | 18.85% | $118M | 12.15% | CNP +6.7pp |
| Net income | $331M | 15.11% | $170M | 17.51% | LNT +2.4pp |
| Stage | CNP | LNT | Gap · A − B |
|---|---|---|---|
| Revenue | $2.2B100.00% | $971M100.00% | CNP ×2.26 |
| Gross profit | 57.33%$1.3B | 66.63%$647M | LNT +9.3pp |
| Operating income | 30.44%$667M | 19.05%$185M | CNP +11.4pp |
| Pre-tax income | 18.85%$413M | 12.15%$118M | CNP +6.7pp |
| Net income |
| 15.11%$331M |
| 17.51%$170M |
| LNT +2.4pp |
No shared counterparties.